Miren Zuazo

2.0k total citations
27 papers, 1.4k citations indexed

About

Miren Zuazo is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Miren Zuazo has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Miren Zuazo's work include Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (10 papers) and CAR-T cell therapy research (7 papers). Miren Zuazo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (10 papers) and CAR-T cell therapy research (7 papers). Miren Zuazo collaborates with scholars based in Spain, United Kingdom and Belgium. Miren Zuazo's co-authors include David Escors, Hugo Arasanz, Grazyna Kochan, María Gato, Ruth Vera, María Ibáñez-Vea, Ana Bocanegra, G. Fernández-Hinojal, María Jesús García-Granda and Karine Breckpot and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Miren Zuazo

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miren Zuazo Spain 17 1.0k 760 296 195 123 27 1.4k
María Gato Spain 16 848 0.8× 766 1.0× 306 1.0× 147 0.8× 116 0.9× 23 1.3k
Hugo Arasanz Spain 20 1.3k 1.2× 940 1.2× 354 1.2× 251 1.3× 140 1.1× 57 1.8k
Justin D. Saco United States 4 966 0.9× 792 1.0× 368 1.2× 216 1.1× 142 1.2× 5 1.4k
Tuba N. Gide Australia 12 1.3k 1.3× 985 1.3× 385 1.3× 240 1.2× 147 1.2× 22 1.7k
Crescenzo D’Alterio Italy 19 849 0.8× 533 0.7× 371 1.3× 172 0.9× 186 1.5× 36 1.3k
Lawrence P. Andrews United States 11 1.3k 1.2× 1.1k 1.5× 392 1.3× 244 1.3× 159 1.3× 14 1.9k
Jingwei Sun China 11 717 0.7× 753 1.0× 438 1.5× 193 1.0× 109 0.9× 22 1.3k
Rong En Tay United States 5 890 0.9× 894 1.2× 571 1.9× 153 0.8× 173 1.4× 8 1.5k
Nana-Ama A.S. Anang United States 4 973 1.0× 762 1.0× 223 0.8× 162 0.8× 76 0.6× 6 1.2k
Julien Faget France 17 804 0.8× 1.2k 1.5× 279 0.9× 121 0.6× 105 0.9× 22 1.5k

Countries citing papers authored by Miren Zuazo

Since Specialization
Citations

This map shows the geographic impact of Miren Zuazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miren Zuazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miren Zuazo more than expected).

Fields of papers citing papers by Miren Zuazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miren Zuazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miren Zuazo. The network helps show where Miren Zuazo may publish in the future.

Co-authorship network of co-authors of Miren Zuazo

This figure shows the co-authorship network connecting the top 25 collaborators of Miren Zuazo. A scholar is included among the top collaborators of Miren Zuazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miren Zuazo. Miren Zuazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chocarro, Luisa, Ester Blanco, Leticia Fernández, et al.. (2024). PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Molecular Medicine. 16(8). 1791–1816. 11 indexed citations
2.
3.
Arasanz, Hugo, Ana Bocanegra, Idoia Morilla, et al.. (2022). Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 14(16). 3846–3846. 26 indexed citations
4.
Ridder, Kirsten De, Hanne Locy, Miren Zuazo, et al.. (2022). TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy. Frontiers in Immunology. 13. 811867–811867. 14 indexed citations
5.
Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2021). Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences. 22(7). 3736–3736. 20 indexed citations
6.
Arasanz, Hugo, Ana Bocanegra, Miren Zuazo, et al.. (2021). 1305P Peripheral low-density neutrophils in the response to immunotherapy in untreated non-small cell lung cancer. Annals of Oncology. 32. S1008–S1008. 1 indexed citations
7.
Chocarro, Luisa, Ester Blanco, Miren Zuazo, et al.. (2021). Understanding LAG-3 Signaling. International Journal of Molecular Sciences. 22(10). 5282–5282. 144 indexed citations
8.
Arasanz, Hugo, Carlos Hernández, Ana Bocanegra, et al.. (2020). Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition. Cancers. 12(8). 2181–2181. 7 indexed citations
9.
Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2020). Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics. Cancers. 12(2). 344–344. 58 indexed citations
10.
Hernández, Carlos, Hugo Arasanz, Luisa Chocarro, et al.. (2020). Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. International Journal of Molecular Sciences. 21(7). 2411–2411. 27 indexed citations
11.
Zuazo, Miren, Hugo Arasanz, Ana Bocanegra, et al.. (2020). Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy. Frontiers in Immunology. 11. 586907–586907. 54 indexed citations
12.
Chocarro, Luisa, Miren Zuazo, Hugo Arasanz, et al.. (2020). 17P Engineering and expression of constitutive activators of the PD-1 and LAG-3 signaling pathways. Annals of Oncology. 31. S250–S250. 1 indexed citations
13.
Chocarro, Luisa, Miren Zuazo, Hugo Arasanz, et al.. (2020). Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?. Frontiers in Pharmacology. 11. 441–441. 69 indexed citations
14.
Bocanegra, Ana, Ester Blanco, G. Fernández-Hinojal, et al.. (2020). PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy. International Journal of Molecular Sciences. 21(16). 5918–5918. 19 indexed citations
15.
Zuazo, Miren, Hugo Arasanz, G. Fernández-Hinojal, et al.. (2019). Functional systemic CD 4 immunity is required for clinical responses to PD ‐L1/ PD ‐1 blockade therapy. EMBO Molecular Medicine. 11(7). e10293–e10293. 143 indexed citations
16.
Escors, David, María Gato, Miren Zuazo, et al.. (2018). The intracellular signalosome of PD-L1 in cancer cells. Signal Transduction and Targeted Therapy. 3(1). 26–26. 215 indexed citations
17.
Ibáñez-Vea, María, Honggang Huang, Xabier Martínez de Morentin, et al.. (2018). Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO2 Chromatography. Journal of Proteome Research. 17(3). 1172–1182. 24 indexed citations
18.
Gato, María, Miren Zuazo, Hugo Arasanz, et al.. (2017). PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. Cell Reports. 20(8). 1818–1829. 223 indexed citations
19.
Zuazo, Miren, María Gato, María Ibáñez-Vea, et al.. (2017). Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy. Annals of Translational Medicine. 5(19). 385–385. 55 indexed citations
20.
Ibáñez-Vea, María, Miren Zuazo, María Gato, et al.. (2017). Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives. Archivum Immunologiae et Therapiae Experimentalis. 66(2). 113–123. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Gato Breakdown of academic impact, for papers by Hugo Arasanz Breakdown of academic impact, for papers by Justin D. Saco Breakdown of academic impact, for papers by Tuba N. Gide Breakdown of academic impact, for papers by Crescenzo D’Alterio Breakdown of academic impact, for papers by Lawrence P. Andrews Breakdown of academic impact, for papers by Jingwei Sun Breakdown of academic impact, for papers by Rong En Tay Breakdown of academic impact, for papers by Nana-Ama A.S. Anang Breakdown of academic impact, for papers by Julien Faget
Rankless by CCL
2026